Binge Eating Disorder: Pathophysiology, Diagnostic Criteria, Comorbidity, and Evidence-Based Treatment Strategies

Binge Eating Disorder (BED) is a psychiatric eating disorder defined by recurrent episodes of binge eating—consuming an objectively large amount of food with a subjective sense of loss of control—without recurrent inappropriate compensatory behaviors (unlike bulimia nervosa). BED is clinically important because it is associated with substantial distress, impaired psychosocial functioning, and elevated risk for obesity-related comorbidities, depression, anxiety disorders, and metabolic disease.

Core diagnostic features include binge-eating episodes occurring, on average, at least once per week for a sustained period (typically 3 months), paired with marked distress and loss of control during the episode. Diagnostic assessment also considers characteristic behavioral features such as eating much more rapidly than normal, eating until uncomfortably full, eating large amounts when not physically hungry, eating alone due to embarrassment, and subsequent feelings of disgust, depression, or guilt. While body weight may vary, BED can occur across weight categories; thus, evaluation should not be limited to BMI or adiposity alone.

The pathophysiology is multifactorial. Dysregulation of reward processing is a central mechanism: binge episodes are often maintained by heightened sensitivity to hedonic cues (e.g., palatable foods, stress-related triggers) alongside impaired inhibitory control. Neurobiologically, BED has been linked to alterations in dopaminergic signaling, stress-axis function, and appetite-regulatory pathways involving leptin, ghrelin, insulin, and gut-brain communication. Functional imaging studies suggest abnormal activation patterns in frontostriatal circuits responsible for self-control and in limbic regions involved in emotion and reward.

Learning and cognitive factors also contribute. Many individuals with BED report dietary restraint, followed by rebound overeating and persistent preoccupation with food, body image, or dieting. Cognitive models emphasize dysfunctional beliefs (e.g., “I cannot stop once I start”) and emotion-focused coping, where binge eating becomes a maladaptive strategy to regulate negative affect. Stress can precipitate binge episodes through both physiologic arousal and learned associations between emotional states and food intake.

Comorbidity is common and clinically relevant. Major depressive disorder and anxiety disorders frequently co-occur, likely reflecting shared mechanisms such as rumination, emotion dysregulation, and stress-related neuroendocrine changes. BED also has high bidirectional relationships with obesity: binge cycles may promote weight gain, while stigma, metabolic changes, and chronic inflammation can worsen mood and motivation, perpetuating the disorder.

Evidence-based treatment is multimodal and individualized. Psychological interventions are first-line for many patients. Cognitive Behavioral Therapy (CBT) for BED targets binge triggers, restructuring of maladaptive thoughts, and development of regular eating patterns that reduce physiological hunger-driven urges. CBT also includes coping-skills training for cravings, problem-solving for high-risk situations, and relapse-prevention planning.

Interpersonal Psychotherapy (IPT) for BED focuses on the interpersonal context of binge eating, addressing role transitions, interpersonal disputes, grief, and deficits in social support. The rationale is that improving relationship functioning and communication can reduce emotional triggers and improve self-regulation.

Pharmacotherapy may be appropriate for moderate-to-severe BED, especially when psychological therapy is insufficient or access is limited. Lisdexamfetamine (a stimulant prodrug) is approved in some regions for BED and can reduce binge frequency through modulation of dopaminergic and noradrenergic pathways and effects on appetite regulation. Selective serotonin reuptake inhibitors (SSRIs) may help with comorbid depression and anxiety and can reduce binge severity in some patients. Topiramate has also shown benefit in some studies by influencing satiety and reducing impulsive eating behaviors, though side effect profiles require careful monitoring.

Nutritional and lifestyle approaches should be delivered carefully. While weight-loss strategies may be considered for those with obesity, aggressive dieting can exacerbate restriction-binge cycles. Instead, clinicians often emphasize consistent meal structure, gradual behavioral changes, and patient-centered goals.

Clinicians should assess risk factors and screen for safety concerns, including severe depression, suicidal ideation, substance use, and medical complications related to metabolic syndrome. Long-term outcomes depend on adherence, comorbid condition management, and addressing stigma and shame.

In summary, BED is a disorder of loss of control around eating driven by intertwined neurobiological reward and inhibitory-control mechanisms, stress and cognitive factors, and often significant mood and anxiety comorbidity. Effective care typically combines structured psychotherapy with, when indicated, pharmacologic options, aiming not only to reduce binge episodes but also to improve coping, emotional regulation, and overall quality of life.

Source: @hesoraw7